Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Soleno Therapeutics Inc (SLNO)
NASDAQ:SLNO
RESEARCH TOOLSreports
Soleno Therapeutics (SLNO) Stock Price & Analysis
538 Followers
SLNO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.85 - $30.30
Previous Close$29.51
Volume976.29K
Average Volume (3M)1.01M
Market Cap
$294.87M
Enterprise Value$275.99M
Total Cash (Recent Filing)$19.37M
Total Debt (Recent Filing)$485.00K
Price to Earnings (P/E)-9.7
Beta0.42
Next Earnings
Nov 15, 2023EPS Estimate
-$0.55Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.04
Shares Outstanding9,992,178
10 Day Avg. Volume6,048,789
30 Day Avg. Volume1,008,927
Standard Deviation0.27
R-Squared0.00086
Alpha0.00091
Financial Highlights & Ratios
Price to Book (P/B)109.01
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-14.94
Forecast
1Y Price Target
$37.67Price Target Upside42.26% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Soleno Therapeutics News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SLNO FAQ
What was Soleno Therapeutics Inc’s price range in the past 12 months?
Soleno Therapeutics Inc lowest stock price was $0.85 and its highest was $30.30 in the past 12 months.
What is Soleno Therapeutics Inc’s market cap?
Currently, no data Available
When is Soleno Therapeutics Inc’s upcoming earnings report date?
Soleno Therapeutics Inc’s upcoming earnings report date is Nov 15, 2023 which is in 43 days.
How were Soleno Therapeutics Inc’s earnings last quarter?
Soleno Therapeutics Inc released its earnings results on Aug 08, 2023. The company reported -$0.81 earnings per share for the quarter, beating the consensus estimate of -$0.827 by $0.017.
Is Soleno Therapeutics Inc overvalued?
According to Wall Street analysts Soleno Therapeutics Inc’s price is currently Undervalued.
Does Soleno Therapeutics Inc pay dividends?
Soleno Therapeutics Inc does not currently pay dividends.
What is Soleno Therapeutics Inc’s EPS estimate?
Soleno Therapeutics Inc’s EPS estimate is -$0.55.
How many shares outstanding does Soleno Therapeutics Inc have?
Soleno Therapeutics Inc has 9,992,178 shares outstanding.
What happened to Soleno Therapeutics Inc’s price movement after its last earnings report?
Soleno Therapeutics Inc reported an EPS of -$0.81 in its last earnings report, beating expectations of -$0.827. Following the earnings report the stock price went down -1.365%.
Which hedge fund is a major shareholder of Soleno Therapeutics Inc?
Among the largest hedge funds holding Soleno Therapeutics Inc’s share is Perceptive Advisors LLC. It holds Soleno Therapeutics Inc’s shares valued at 9M.
---
Soleno Therapeutics Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$37.67 (42.26% Upside)
$37.67 (42.26% Upside)
Hedge Fund Trend
Increased
By 2.1M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $22.6M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
1710.42%
12-Months-Change
Fundamentals
Return on Equity
-173.82%
Trailing 12-Months
Asset Growth
-16.05%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Soleno Therapeutics Inc
Soleno Therapeutics, Inc. engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It markets CoSense End-Tidal Carbon Monoxide monitor, which measures ETCO and is used by hospitals to detect hemolysis in newborns. The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.
---
Top 5 ETFs holding SLNO
iShares Core S&P Total U.S. Stock Market ETF
$1.15K
Up to five ETFs with an Outperform Smart Score that hold SLNO. The ETFs are listed according to market value of SLNO within the ETF
Agile Therapeutics
―
Regulus
―
Invivo Therapeutics Holdings
―
Pieris Pharmaceuticals
―
---